Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Boston Scientific picks up afib player Apama in deal worth up to $300M

fiercebiotechOctober 17, 2017

Tag: Boston Scientific , Apama , $300M

PharmaSources Customer Service